Case Study: Fully Integrated CareMetx Program Improves Initiation and Days on Therapy
A leading pharmaceutical manufacturer partnered with CareMetx to improve initiation rates and time on therapy for a self-injected...
CareMetx : Jan 28, 2022 11:00:00 AM
When a provider prescribes a patient a specialty therapy, the next steps often involve a complex navigation of cumbersome, multi-step authorization requirements. Patients must meet these requirements in order to access their care and begin said therapy as prescribed. This impending onslaught of paperwork and phone calls often causes delays that can threaten continuity of care, which is especially troubling for patients with the kind of complex diagnosis and life-threatening conditions that would require a specialty therapy.
A leading pharmaceutical manufacturer partnered with CareMetx to improve initiation rates and time on therapy for a self-injected...
Self-injectable drugs help patients manage chronic conditions from the convenience of home, yet they’re more complicated to administer than oral...
CareMetx worked with a global leader in immunology and dermatology to speed up the process of Benefits Verification and Prior Authorization. CareMetx...